Up And Down The Ladder… Job Changes
Make a commentBy Ed Silverman // March 19th, 2010 // 6:59 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Thomas Hofstaetter has been named ceo and president of VaxInnate, as ceo Alan Shaw becomes chief scientific officer and chairman. Prior to joining VaxInnate, Hofstaetter was sr vp of corporate business development at Wyeth, where he headed global business development for the pharma unit and was a member of the Wyeth Management Committee.
Cytokinetics named Patrick Gage as chairman;
Adeona Pharmaceuticals added Jeff Lucero Riley to its board;
Venn Life Sciences named Dale Trask vp global business development;
Affymetrix hired Timothy Barabe as exec vp and chief financial officer;
Endo Pharmaceuticals hired Julie McHugh as chief operating officer;
Crown Bioscience named Chuan Shih as exec vp, integrated drug discovery services;
Arnold & Porter added former federal health care fraud prosecutor Kirk Ogrosky as a partner;
Qforma hired Carl Kunz, Keith Mangas and Chris Rofidal as business development execs.
Ladder shot thx to Robert CB on Flickr Creative Commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Adeona, Affymetrix, Arnold & Porter, Crown Bioscience, Cytokinetics, Endo Pharmaceuticals, Qforma, VaxInnate, Venn Life Sciences, Wyeth